Godfrey Getz to Atherosclerosis
This is a "connection" page, showing publications Godfrey Getz has written about Atherosclerosis.
Connection Strength
13.747
-
ILRUNing to Atherosclerosis. Arterioscler Thromb Vasc Biol. 2022 09; 42(9):1152-1153.
Score: 0.698
-
Pig and Mouse Models of Hyperlipidemia and Atherosclerosis. Methods Mol Biol. 2022; 2419:379-411.
Score: 0.670
-
Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2020 10; 31(5):286-290.
Score: 0.614
-
Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2020 02; 31(1):35-37.
Score: 0.587
-
Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice. Int J Mol Sci. 2019 Sep 14; 20(18).
Score: 0.571
-
Diet, Microbes, and Murine Atherosclerosis. Arterioscler Thromb Vasc Biol. 2018 10; 38(10):2269-2271.
Score: 0.535
-
Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice. Curr Opin Lipidol. 2017 Oct; 28(5):403-407.
Score: 0.499
-
Natural killer T cells in atherosclerosis. Nat Rev Cardiol. 2017 05; 14(5):304-314.
Score: 0.476
-
Serum amyloid A and atherosclerosis. Curr Opin Lipidol. 2016 10; 27(5):531-5.
Score: 0.466
-
Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis? Arterioscler Thromb Vasc Biol. 2016 09; 36(9):1734-41.
Score: 0.458
-
ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis. J Lipid Res. 2016 05; 57(5):758-66.
Score: 0.449
-
Atherogenic lipids and macrophage subsets. Curr Opin Lipidol. 2015 Oct; 26(5):357-61.
Score: 0.434
-
Use of Mouse Models in Atherosclerosis Research. Methods Mol Biol. 2015; 1339:1-16.
Score: 0.412
-
Myeloperoxidase-mediated dysfunctional high-density lipoprotein. Arterioscler Thromb Vasc Biol. 2014 Apr; 34(4):695-6.
Score: 0.391
-
Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012 May; 32(5):1104-15.
Score: 0.339
-
Atherosclerosis: beyond cholesterol. Curr Opin Lipidol. 2011 Dec; 22(6):507-8.
Score: 0.333
-
Natural killer T cells in lipoprotein metabolism and atherosclerosis. Thromb Haemost. 2011 Nov; 106(5):814-9.
Score: 0.329
-
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J. 2011 Jan; 25(1):290-300.
Score: 0.307
-
ABC transporters: lipid transport and inflammation. Curr Opin Lipidol. 2010 Apr; 21(2):159-60.
Score: 0.297
-
Biological properties of apolipoprotein a-I mimetic peptides. Curr Atheroscler Rep. 2010 Mar; 12(2):96-104.
Score: 0.295
-
HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Curr Pharm Des. 2010; 16(28):3173-84.
Score: 0.292
-
Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Curr Opin Lipidol. 2009 Jun; 20(3):171-5.
Score: 0.280
-
VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res. 2009 Mar; 50(3):376-385.
Score: 0.269
-
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res. 2008 Jun; 49(6):1268-83.
Score: 0.257
-
Murine atherosclerosis. Part III. Curr Drug Targets. 2008 Mar; 9(3):173.
Score: 0.257
-
The immune system and murine atherosclerosis. Curr Drug Targets. 2007 Dec; 8(12):1297-306.
Score: 0.252
-
Overview of murine atherosclerosis series. Curr Drug Targets. 2007 Nov; 8(11):1144-9.
Score: 0.251
-
Nutrition and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2007 Dec; 27(12):2499-506.
Score: 0.250
-
Arginine/arginase NO NO NO. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):237-9.
Score: 0.222
-
Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):242-9.
Score: 0.221
-
Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice. Atherosclerosis. 2006 Aug; 187(2):325-31.
Score: 0.219
-
Apoprotein E and Reverse Cholesterol Transport. Int J Mol Sci. 2018 Nov 06; 19(11).
Score: 0.135
-
Hypercholesterolemia-Induced Loss of Flow-Induced Vasodilation and Lesion Formation in Apolipoprotein E-Deficient Mice Critically Depend on Inwardly Rectifying K+ Channels. J Am Heart Assoc. 2018 03 03; 7(5).
Score: 0.128
-
Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice. Int J Mol Sci. 2018 Feb 08; 19(2).
Score: 0.128
-
The western-type diet induces anti-HMGB1 autoimmunity in Apoe(-/-) mice. Atherosclerosis. 2016 08; 251:31-38.
Score: 0.113
-
Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. J Lipid Res. 2016 Feb; 57(2):246-57.
Score: 0.110
-
Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice. J Am Heart Assoc. 2015 Jul 17; 4(7).
Score: 0.107
-
The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. PLoS One. 2014; 9(10):e109252.
Score: 0.101
-
Cutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE(-/-) mouse model of atherosclerosis. J Immunol. 2014 Jul 01; 193(1):35-9.
Score: 0.099
-
The structure/function of apoprotein A-I mimetic peptides: an update. Curr Opin Endocrinol Diabetes Obes. 2014 Apr; 21(2):129-33.
Score: 0.098
-
Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background. Arterioscler Thromb Vasc Biol. 2014 Feb; 34(2):262-9.
Score: 0.096
-
Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res. 2013 Oct; 54(10):2831-41.
Score: 0.094
-
ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. J Lipid Res. 2013 Jan; 54(1):202-13.
Score: 0.088
-
Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol. 2012 Jul; 26(7):1091-101.
Score: 0.086
-
Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol. 2011 Oct 11; 58(16):1715-27.
Score: 0.082
-
A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. Br J Pharmacol. 2011 Apr; 162(8):1792-804.
Score: 0.079
-
Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J Lipid Res. 2009 Apr; 50 Suppl:S156-61.
Score: 0.067
-
Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J Pharmacol Exp Ther. 2008 Nov; 327(2):332-42.
Score: 0.066
-
Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis. 2009 Mar; 203(1):59-66.
Score: 0.065
-
Serum amyloid A regulates monopoiesis in hyperlipidemic Ldlr(-/-) mice. FEBS Lett. 2016 08; 590(16):2650-60.
Score: 0.029
-
Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein. Arterioscler Thromb Vasc Biol. 2016 06; 36(6):1101-13.
Score: 0.028
-
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med. 2009 Jan 16; 206(1):233-48.
Score: 0.017